STOCK TITAN

Five Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology Day

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Five Prime Therapeutics (NASDAQ: FPRX) announced that CEO Tom Civik and CMO Helen Collins will participate in a fireside chat at the virtual Guggenheim Healthcare Talks: Oncology Day on February 12, 2021, at 1:00 p.m. ET. The session will be accessible via a live audio webcast, with a replay available for 30 days on the Company’s website. Five Prime is a clinical-stage biotechnology firm focused on developing innovative cancer therapies to change treatment paradigms for patients with limited options.

Positive
  • None.
Negative
  • None.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) today announced that Tom Civik, President and Chief Executive Officer, and Helen Collins, M.D., Executive Vice President and Chief Medical Officer, are scheduled to participate in a fireside chat at the virtual Guggenheim Healthcare Talks: Oncology Day on Friday, February 12, 2021 at 1:00 p.m. ET/10:00 a.m. PT.

Live audio webcast of the fireside chat will be accessible and available for replay from the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime Therapeutics

Five Prime is a clinical stage biotechnology company relentlessly focused on rewriting cancer. By tackling the tough scientific questions and untapped pathways, we aim to offer new hope by developing novel, breakthrough therapies that have potential to alter the course of disease in cancers with few treatment options. This vision is what defines us and guides our research, clinical development and partnerships. To build a better tomorrow for people with cancer, we are teaming up with patients, physicians, scientists, and industry partners to make a meaningful difference in patients’ lives. Five Prime collaborates with leading global pharmaceutical companies and has therapies in pre-clinical and clinical development. For more information, please visit www.fiveprime.com.

FAQ

When is Five Prime Therapeutics scheduled to participate in the Guggenheim Healthcare Talks?

Five Prime Therapeutics will participate in the Guggenheim Healthcare Talks on February 12, 2021, at 1:00 p.m. ET.

Where can I watch the Five Prime Therapeutics fireside chat?

The fireside chat can be streamed live and accessed later from the 'Events & Presentations' section of Five Prime's website.

Who will represent Five Prime Therapeutics at the Guggenheim Healthcare Talks?

Tom Civik, the CEO, and Helen Collins, the CMO, will represent Five Prime Therapeutics.

What type of company is Five Prime Therapeutics?

Five Prime Therapeutics is a clinical-stage biotechnology company focused on developing breakthrough cancer therapies.

What is the stock symbol for Five Prime Therapeutics?

The stock symbol for Five Prime Therapeutics is FPRX.

FPRX

NASDAQ:FPRX

FPRX Rankings

FPRX Latest News

FPRX Stock Data

45.24M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
South San Francisco